General Information of MET (ID: META00847) |
Name |
Acetyl-N-formyl-5-methoxykynurenamine
|
Synonyms |
Click to Show/Hide Synonyms of This Metabolite
AFMK; Formyl-N-acetyl-5-methoxykynurenamine; K1; N-Acetyl-N-formyl-5-methoxykynurenamine; N-[3-(2-Formamido-5-methoxy-phenyl)-3-oxo-propyl]acetamide; N1-Acetyl-N2-formyl-5-methoxykynurenine; NSC 688263
|
Source |
Endogenous;Food
|
Structure Type |
Carbonyl compounds (Click to Show/Hide the Complete Structure Type Hierarchy)
Organic oxygen compounds
Organooxygen compounds
Carbonyl compounds
|
PubChem CID |
|
HMDB ID |
|
Formula |
C13H16N2O4
|
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=171161"></iframe>
|
 |
3D MOL
|
2D MOL
|
|
Click to Show/Hide the Molecular/Functional Data (External Links/Property/Function) of This Metabolite
|
KEGG ID |
|
FooDB ID |
|
ChemSpider ID |
|
Physicochemical Properties |
Molecular Weight |
264.28 |
Topological Polar Surface Area |
84.5 |
XlogP |
0.6 |
Complexity |
333 |
Heavy Atom Count |
19 |
Rotatable Bond Count |
6 |
Hydrogen Bond Donor Count |
2 |
Hydrogen Bond Acceptor Count |
4 |
Function |
Acetyl-N-formyl-5-methoxykynurenamine (AFMK) results from the oxidative cleavage of the pyrrole ring during melatonin oxidation by myeloperoxidase (MPO), a superoxide anion (O)-dependent reaction. AFMK is also expected to be formed from oxidation catalyzed by the unspecific enzyme indoleamine-2,3-dioxygenase (IDO), found in a variety of cell types including monocyte/macrophage lineages. MPO- and IDO-catalyzed melatonin oxidation has the requirement of O in common, a species formed in large amounts in inflammatory conditions. The non-enzymatic formation of AFMK can also be expected by its direct reaction with highly reactive oxygen species, such as hydroxyl radical and singlet oxygen. Thus, we assume that AFMK is a product formed in a route of melatonin metabolism, especially active in inflammation. As AFMK is biologically more active on leukocytes than melatonin, the metabolizing of melatonin to AFMK at inflammatory sites possibly plays a role in immunomodulation. AFMK is found in the CSF of patients with meningitis, and in some samples at a remarkably high concentration. AFMK was also found in some patients to exceed the concentration of melatonin normally found in serum.
|
Regulatory Network
|
|
|
|
|
|
|
|